Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2018-03-22 2018-02-22
Drug Identification Number 02392526 02392526
Brand name GABAPENTIN TABLETS USP GABAPENTIN TABLETS USP
Common or Proper name GABAPENTIN GABAPENTIN
Company Name ACCORD HEALTHCARE INC ACCORD HEALTHCARE INC
Ingredients GABAPENTIN GABAPENTIN
Strength(s) 600MG 600MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 TABS PER BOTTLE | BOUTEILLE DE 100 COMPRIMÉS 100 TABS PER BOTTLE | BOUTEILLE DE 100 COMPRIMÉS
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-02-02 2018-02-02
Estimated end date 2018-03-09 2018-03-09
Actual end date 2018-03-16
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments